Back
Columbia Research Enhanced Value ETF 10K Form
Buy
80
REVS
Columbia Research Enhanced Value ETF
Last Price:
26.30
Seasonality Move:
1.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive REVS News And Ratings
See the #1 stock for the next 7 days that we like better than REVS
REVS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Columbia Research Enhanced Value ETF Earnings Forecast
Key Columbia Research Enhanced Value ETF Financial Ratios
Columbia Research Enhanced Value ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSEARCA |
|---|---|
| Current Symbol: | REVS |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
REVS Technical Analysis vs Fundamental Analysis
Buy
80
Columbia Research Enhanced Value ETF (REVS)
is a Buy
Is Columbia Research Enhanced Value ETF a Buy or a Sell?
-
Columbia Research Enhanced Value ETF stock is rated a Buy
The current Columbia Research Enhanced Value ETF [REVS] share price is $26.53. The Score for REVS is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.